The effectiveness and value of belimumab and voclosporin for lupus nephritis: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council

Detalles Bibliográficos
Autores principales: Tice, Jeffrey A, Mandrik, Olena, Thokala, Praveen, Fotheringham, James, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391090/
https://www.ncbi.nlm.nih.gov/pubmed/34595943
http://dx.doi.org/10.18553/jmcp.2021.27.10.1495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391090/
https://www.ncbi.nlm.nih.gov/pubmed/34595943
http://dx.doi.org/10.18553/jmcp.2021.27.10.1495

Ejemplares similares